Bayer said Wednesday its pharmaceuticals unit will likely see a decline in sales in 2025 as the company reported another set ...

The January decline means that the slow declining trend in retail sales continues despite significant purchasing power gains ...

Return on equity is expected above 12%, although it most notably excludes the €0.7 billion post-tax hit from the sale of ING's onshore Russia business (set to close in Q3 2025). The sale will ...

On the other hand, government measures towards the end of the year could provide a further boost to consumption and retail sales turnover. In the light of the past two years, we can therefore expect a ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

Europe had been banking on a United States that wanted to make a deal on tariffs and trade. With little progress in that ...

The piece, sold to a private collector, had been projected to sell for three to five million pounds. Sotheby's said the ...

Retail sales dropped 0.9% last month ... chief international economist at ING. “We will need to wait until the February data to see if this is the start of a more cautious consumer trend ...

Retail sales dropped 0.9% last month ... chief international economist at ING.

Retail sales dropped 0.9% last month ... chief international economist at ING. "We will need to wait until the February data to see if this is the start of a more cautious consumer trend or ...

The decrease in service sales was primarily due to a $5.1 million decrease in ... Other trademarks are the property of their respective companies. KVH Industries Ing. NewsMORE Related Stocks ...

For grains, hope of maintaining trade flows to the biggest buyers of U.S. agriculture are buoying futures. Most-active corn futures are up 1.3%. Soybeans rise 0.8%, and wheat climbs 0.9%.